Barclays analyst Charles Pitman CFA reiterated a Buy rating on UCB SA (0NZT – Research Report) today and set a price target of €240.00. The ...

United Community Banks, Inc. (NYSE: UCB) announces it will release its first quarter 2025 financial results on Tuesday, April 22, 2025, before the stock market opens. The company also will hold a ...

"We see China as a source of innovation, and the country has made tremendous strides in creating an ecosystem that empowers ...

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

Can partnering ensure future success for pharma? UCB is very receptive to outside engagement. There is a real understanding within the company that being internally focussed and concentrating ...

Adia Nutrition (OTC Pink: ADIA), a trailblazer in advanced healthcare solutions, is excited to announce that its subsidiary, ...

The October 2022 penalty was for abusing its dominant position in mobile app markets through its Android Play Store.

The Business Research Company The Business Research Company's Myocarditis Disease Global Market Report 2025 – Market Size, Trends, And Glob ...

Shares in UCB slid this morning after the Belgian company announced its refractory epilepsy drug candidate padsevonil had failed a phase 2b trial. The ARISE trial of padsevonil did not reach ...

It may be its own unique take on the late night format, but 'Everybody's Live with John Mulaney' owes a lot to these ...